Skip to main content
. 2021 Jan 11;9(2):1860616. doi: 10.1080/21688370.2020.1860616

Figure 2.

Figure 2.

P-gp and BCRP function 4 h or 24 h after treatment with LPS (a-d), PolyI:C (e-h) or ssRNA (i-l), measured using the Ca-AM and Ce6 assays. Doses: 103–106 pg/mL. N = 6/group. Values are expressed as a percentage of control (vehicle) groups. Data are presented as mean ± SEM. Statistical analysis: Kruskal-Wallis test, followed by Dunn’s multiple comparison test. *p < .05, and **p < .01